Comparative Study Using 100–300 Versus 300–500 μm Microspheres for Symptomatic Patients Due to Enlarged-BPH Prostates
- 10 August 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in CardioVascular and Interventional Radiology
- Vol. 39 (10), 1372-1378
- https://doi.org/10.1007/s00270-016-1443-x
Abstract
The purpose of the study was to compare safety and efficacy outcomes following prostate artery embolization (PAE) for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) with 100–300 versus 300–500 μm tris-acryl gelatin microspheres. Patients were prospectively treated between August 2011 and June 2013 to receive PAE with 100–300 μm (group A) or 300–500 μm (group B) tris-acryl gelatin microspheres. Patients were followed for a minimum of 12 months and were assessed for changes in International Prostate Symptom Score (IPSS), quality of life (QoL) index, prostate volume determined by magnetic resonance imaging, serum prostate specific antigen (PSA), and maximum urine flow rate (Qmax), as well as any treatment-related adverse events. Fifteen patients were included in each group, and PAE was technically successful in all cases. Both groups experienced significant improvement in mean IPSS, QoL, prostate volume, PSA, and Qmax (p < 0.05 for all). The differences observed between the two groups included a marginally insignificant more adverse events (p = 0.066) and greater mean serum PSA reduction at 3 months of follow-up (p = 0.056) in group A. Both 100–300 and 300–500 μm microspheres are safe and effective embolic agents for PAE to treat LUTS-related to BPH. Although functional and imaging outcomes did not differ significantly following use of the two embolic sizes, the greater incidence of adverse events with 100–300 μm microspheres suggests that 300–500 μm embolic materials may be more appropriate.Keywords
This publication has 18 references indexed in Scilit:
- The “PErFecTED Technique”: Proximal Embolization First, Then Embolize Distal for Benign Prostatic HyperplasiaCardioVascular and Interventional Radiology, 2014
- Does Polyvinyl Alcohol Particle Size Change the Outcome of Prostatic Arterial Embolization for Benign Prostatic Hyperplasia? Results from a Single-Center Randomized Prospective StudyJournal of Vascular and Interventional Radiology, 2013
- Transient Ischemic Rectitis as a Potential Complication after Prostatic Artery Embolization: Case Report and Review of the LiteratureCardioVascular and Interventional Radiology, 2013
- Prostatic Artery Embolization for Enlarged Prostates Due to Benign Prostatic Hyperplasia. How I Do ItCardioVascular and Interventional Radiology, 2013
- Quality of Life and Clinical Symptom Improvement Support Prostatic Artery Embolization for Patients with Acute Urinary Retention Caused by Benign Prostatic HyperplasiaJournal of Vascular and Interventional Radiology, 2013
- Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-upEuropean Radiology, 2013
- Midterm Follow-Up After Prostate Embolization in Two Patients with Benign Prostatic HyperplasiaCardioVascular and Interventional Radiology, 2011
- Prostatic Arterial Embolization to Treat Benign Prostatic HyperplasiaJournal of Vascular and Interventional Radiology, 2011
- Prostatic Artery Embolization as a Primary Treatment for Benign Prostatic Hyperplasia: Preliminary Results in Two PatientsCardioVascular and Interventional Radiology, 2009
- Relief of Benign Prostatic Hyperplasia-related Bladder Outlet Obstruction after Transarterial Polyvinyl Alcohol Prostate EmbolizationJournal of Vascular and Interventional Radiology, 2000